U.S. federal trademark · Serial No. 78961832 · Reg. No. 3566066
Pharmaceutical substances based on affinity reagents of immunoglobulin or non-immunoglobulin origin for cancer diagnostics, prognostics, and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection, and in-vivo imaging, mainly for cancer cells, in-vitro or in-vivo, all for medical or diagnostic purposes; biological preparations for pharmaceutical use for cancer diagnostics, prognostics, and treatment
Scientific and medical research and developments within the field of biochemistry and biotechnology, diagnostics and pharmaceutical or medical substances and preparations
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.